Additionally, upregulated HGF was found to induce cetuximab resistance in CRC cells via the binding with SRY-Box Transcription Factor 8 (SOX8), indicating the crucial role of SOX8/HGF/MET in the CRC therapy resistance (Piao et al., 2022). The gene discussed is MET; the disease is colorectal carcinoma.